[1]
|
Bray, F., Laversanne, M., Weiderpass, E. and Soerjomataram, I. (2021) The Ever-Increasing Importance of Cancer as a Leading Cause of Premature Death Worldwide. Cancer, 127, 3029-3030. https://doi.org/10.1002/cncr.33587
|
[2]
|
Sung, H., Ferlay, J., Siegel, R., Laversanne, M., Soerjomataram, I. Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[3]
|
Tsvetkov, P., Coy, S., Petrova, B., et al. (2022) Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins. Science, 375, 1254-1261. https://doi.org/10.1126/science.abf0529
|
[4]
|
Solmonson, A. and DeBerardinis, R.J. (2018) Lipoic Acid Metabo-lism and Mitochondrial Redox Regulation. Journal of Biological Chemistry, 293, 7522-7530. https://doi.org/10.1074/jbc.TM117.000259
|
[5]
|
Rowland, E.A., Snowden, C.K. and Cristea, I.M. (2018) Protein Lipoylation: An Evolutionarily Conserved Metabolic Regulator of Health and Disease. Current Opinion in Chemical Bi-ology, 42, 76-85.
https://doi.org/10.1016/j.cbpa.2017.11.003
|
[6]
|
Tsvetkov, P., Detappe, A., Cai, K., et al. (2019) Mitochondrial Metabolism Promotes Adaptation to Proteotoxic Stress. Nature Chemical Biology, 15, 681-689. https://doi.org/10.1038/s41589-019-0291-9
|
[7]
|
da Silva, D.A., De Luca, A., Squitti, R., et al. (2022) Copper in Tumors and the Use of Copper-Based Compounds in Cancer Treatment. Journal of Inorganic Biochemistry, 226, Article ID: 111634.
https://doi.org/10.1016/j.jinorgbio.2021.111634
|
[8]
|
Park, K.C., Fouani, L., Jansson, P.J., et al. (2016) Copper and Conquer: Copper Complexes of Di-2-Pyridylketone Thiosemicarbazones as Novel Anti-Cancer Therapeutics. Metallom-ics, 8, 874-886.
https://doi.org/10.1039/C6MT00105J
|
[9]
|
Ge, E.J., Bush, A.I., Casini, A., et al. (2022) Connecting Copper and Cancer: From Transition Metal Signalling to Metalloplasia. Nature Reviews Cancer, 22, 102-113. https://doi.org/10.1038/s41568-021-00417-2
|
[10]
|
Bandmann, O., Weiss, K.H. and Kaler, S.G. (2015) Wilson’s Disease and Other Neurological Copper Disorders. The Lancet Neurology, 14, 103-113. https://doi.org/10.1016/S1474-4422(14)70190-5
|
[11]
|
Gaggelli, E., Kozlowski, H., Valensin, D. and Valensin, G. (2006) Copper Homeostasis and Neurodegenerative Disorders (Alzheimer’s, Prion, and Parkinson’s Diseases and Amy-otrophic Lateral Sclerosis). Chemical Reviews, 106, 1995-2044. https://doi.org/10.1021/cr040410w
|
[12]
|
Tang, D., Chen, X. and Kroemer, G. (2022) Cuproptosis: A Copper-Triggered Modality of Mitochondrial Cell Death. Cell Re-search, 32, 417-418. https://doi.org/10.1038/s41422-022-00653-7
|
[13]
|
Feng, Y., Zeng, J.-W., Ma, Q., et al. (2020) Serum Copper and Zinc Levels in Breast Cancer: A Meta-Analysis. Journal of Trace Elements in Medicine and Biology, 62, Article ID: 126629. https://doi.org/10.1016/j.jtemb.2020.126629
|
[14]
|
Lossow, K., Schwarz, M. and Kipp, A.P. (2021) Are Trace Element Concentrations Suitable Biomarkers for the Diagnosis of Cancer? Redox Biology, 42, Article ID: 101900. https://doi.org/10.1016/j.redox.2021.101900
|
[15]
|
Wang, W., Wang, X., Luo, J., et al. (2021) Serum Copper Level and the Copper-to-Zinc Ratio Could Be Useful in the Prediction of Lung Cancer and Its Prognosis: A Case-Control Study in Northeast China. Nutrition and Cancer, 73, 1908-1915. https://doi.org/10.1080/01635581.2020.1817957
|
[16]
|
Denoyer, D., Masaldan, S., La Fontaine, S. and Cater, M.A. (2015) Targeting Copper in Cancer Therapy: ‘Copper That Cancer’. Metallomics, 7, 1459-1476. https://doi.org/10.1039/C5MT00149H
|
[17]
|
Nagai, M., Vo, N.H., Shin Ogawa, L., et al. (2012) The Oncology Drug Elesclomol Selectively Transports Copper to the Mitochondria to Induce Oxidative Stress in Cancer Cells. Free Radical Biology and Medicine, 52, 2142-2150.
https://doi.org/10.1016/j.freeradbiomed.2012.03.017
|
[18]
|
Kumar, P. and Aggarwal, R. (2016) An Overview of Triple-Negative Breast Cancer. Archives of Gynecology and Obstetrics, 293, 247-269. https://doi.org/10.1007/s00404-015-3859-y
|
[19]
|
Cocco, S., Piezzo, M., Calabrese, A., et al. (2020) Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives. International Journal of Molecular Sciences, 21, Article No. 4579.
https://doi.org/10.3390/ijms21134579
|
[20]
|
Sha, S., Si, L., Wu, X., et al. (2022) Prognostic Analysis of Cupropto-sis-Related Gene in Triple-Negative Breast Cancer. Frontiers in Immunology, 13, Article 922780. https://doi.org/10.3389/fimmu.2022.922780
|
[21]
|
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P.W., Levine, D.A., Carter, S.L., Getz, G., Stemke-Hale, K., Mills, G.B. and Verhaak, R.G. (2013) Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expres-sion Data. Nature Communications, 4, Article 2612. https://doi.org/10.1038/ncomms3612
|
[22]
|
Karaayvaz, M., Cristea, S., Gillespie, S.M., et al. (2018) Unravelling Subclonal Heterogeneity and Aggressive Disease States in TNBC through Single-Cell RNA-Seq. Nature Communications, 9, Article No. 3588.
https://doi.org/10.1038/s41467-018-06052-0
|
[23]
|
Deepak, K.G.K., Vempati, R., Nagaraju, G.P., et al. (2020) Tu-mor Microenvironment: Challenges and Opportunities in Targeting Metastasis of Triple Negative Breast Cancer. Phar-macological Research, 153, Article ID: 104683.
https://doi.org/10.1016/j.phrs.2020.104683
|
[24]
|
Schmid, P., Rugo, H.S., Adams, S., et al. (2020) Atezolizumab Plus Nab-Paclitaxel as First-Line Treatment for Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer (IMpassion130): Updated Efficacy Results From a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. The Lancet Oncology, 21, 44-59.
https://doi.org/10.1016/S1470-2045(19)30689-8
|
[25]
|
Wu, Y., Kyle-Cezar, F., Woolf, R.T., et al. (2019) An In-nate-Like Vδ1+ γδ T Cell Compartment in the Human Breast Is Associated with Remission in Triple-Negative Breast Cancer. Science Translational Medicine, 11, Article No. eaax9364. https://doi.org/10.1126/scitranslmed.aax9364
|
[26]
|
Zhang, S.-C., Hu, Z.-Q., Long, J.-H., et al. (2019) Clinical Im-plications of Tumor-Infiltrating Immune Cells in Breast Cancer. Journal of Cancer, 10, 6175-6184. https://doi.org/10.7150/jca.35901
|
[27]
|
Vito, A., Salem, O., El-Sayes, N., et al. (2021) Immune Checkpoint Block-ade in Triple Negative Breast Cancer Influenced by B Cells through Myeloid-Derived Suppressor Cells. Communications Biology, 4, Article No. 859.
https://doi.org/10.1038/s42003-021-02375-9
|
[28]
|
Toney, N.J., Opdenaker, L.M., Cicek, K., et al. (2022) Tu-mor-B-Cell Interactions Promote Isotype Switching to an Immunosuppressive Igg4 Antibody Response Through Upreg-ulation of IL-10 in Triple Negative Breast Cancers. Journal of Translational Medicine, 20, Article No. 112. https://doi.org/10.1186/s12967-022-03319-5
|
[29]
|
Huang, A.C. and Zappasodi, R. (2022) A Decade of Checkpoint Blockade Immunotherapy in Melanoma: Understanding the Molecular Basis for Immune Sensitivity and Resistance. Na-ture Immunology, 23, 660-670.
https://doi.org/10.1038/s41590-022-01141-1
|
[30]
|
Banach, K., Kowalska, J., Rzepka, Z., et al. (2021) The Role of UVA Radiation in Ketoprofen-Mediated BRAF-Mutant Amelanotic Melanoma Cells Death—A Study at the Cellular and Molecular Level. Toxicology in Vitro, 72, Article ID: 105108. https://doi.org/10.1016/j.tiv.2021.105108
|
[31]
|
Moyers, J.T. and Glitza Oliva, I.C. (2021) Immunotherapy for Mel-anoma. In: Naing, A. and Hajjar, J., Eds., Immunotherapy. Advances in Experimental Medicine and Biology, Vol. 1342, Springer, Cham, 81-111.
https://doi.org/10.1007/978-3-030-79308-1_3
|
[32]
|
Mayr, J.A., Feichtinger, R.G., Tort, F., Ribes, A. and Sperl, W. (2014) Lipoic Acid Biosynthesis Defects. Journal of Inherited Metabolic Disease, 37, 553-563. https://doi.org/10.1007/s10545-014-9705-8
|
[33]
|
Solmonson, A., Faubert, B., Gu, W., et al. (2022) Compart-mentalized Metabolism Supports Midgestation Mammalian Development. Nature, 604, 349-353. https://doi.org/10.1038/s41586-022-04557-9
|
[34]
|
Lv, H., Liu, X., Zeng, X., et al. (2022) Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma. Frontiers in Pharmacology, 13, Arti-cle ID: 930041.
https://doi.org/10.3389/fphar.2022.930041
|
[35]
|
Sosman, J.A., Kim, K.B., Schuchter, L., et al. (2012) Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib. New England Journal of Medicine, 366, 707-714. https://doi.org/10.1056/NEJMoa1112302
|
[36]
|
Tang, D., Kang, R., Berghe, T.V., Vandenabeele, P. and Kroemer, G. (2019) The Molecular Machinery of Regulated Cell Death. Cell Research, 29, 347-364. https://doi.org/10.1038/s41422-019-0164-5
|
[37]
|
Brady, D.C., Crowe, M.S., Turski, M.L., et al. (2014) Copper Is Required for Oncogenic BRAF Signaling and Tumorigenesis. Nature, 509, 492-496. https://doi.org/10.1038/nature13180
|
[38]
|
Ayers, M., Lunceford, J., Nebozhyn, M., et al. (2017) IFN-γ-Related mRNA Profile Predicts Clinical Response to PD-1 Blockade. Journal of Clinical Investigation, 127, 2930-2940. https://doi.org/10.1172/JCI91190
|
[39]
|
Grasso, C.S., Tsoi, J., Onyshchenko, M., et al. (2020) Conserved Interfer-on-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. Cancer Cell, 38, 500-515.
https://doi.org/10.1016/j.ccell.2020.08.005
|
[40]
|
Kim, Y.J., Sheu, K.M., Tsoi, J., et al. (2021) Melanoma Dediffer-entiation Induced by IFN-γ Epigenetic Remodeling in Response to Anti-PD-1 Therapy. Journal of Clinical Investigation, 131, e145859. https://doi.org/10.1172/JCI145859
|
[41]
|
Nguyen, T.-T., Ramsay, L., Ahanfeshar-Adams, M., et al. (2021) Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment. Clinical Cancer Research, 27, 3432-3442. https://doi.org/10.1158/1078-0432.CCR-20-3365
|
[42]
|
Jonasch, E., Gao, J. and Rathmell, W.K. (2014) Renal Cell Carcinoma. BMJ, 349, Article No. g4797.
https://doi.org/10.1136/bmj.g4797
|
[43]
|
Lalani, A.-A., McGregor, B.A., Albiges, L., et al. (2019) Systemic Treat-ment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Di-rections. European Urology, 75, 100-110.
https://doi.org/10.1016/j.eururo.2018.10.010
|
[44]
|
Jonasch, E., Walker, C.L. and Rathmell, W.K. (2021) Clear Cell Renal Cell Carcinoma Ontogeny and Mechanisms of Lethality. Nature Reviews Nephrology, 17, 245-261. https://doi.org/10.1038/s41581-020-00359-2
|
[45]
|
Linehan, W.M., Schmidt, L.S., Crooks, D.R., et al. (2019) The Metabolic Basis of Kidney Cancer. Cancer Discovery, 9, 1006-1021. https://doi.org/10.1158/2159-8290.CD-18-1354
|
[46]
|
Cancer Genome Atlas Research Network (2013) Comprehen-sive Molecular Characterization of Clear Cell Renal Cell Carcinoma. Nature, 499, 43-49. https://doi.org/10.1038/nature12222
|
[47]
|
Bian, Z., Fan, R. and Xie, L. (2022) A Novel Cuproptosis-Related Prog-nostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Genes, 13, Article No. 851.
https://doi.org/10.3390/genes13050851
|
[48]
|
Singh, D., Narayanamoorthy, S., Gamre, S., et al. (2018) Hydroxy-chavicol, a Key Ingredient of Piper betle Induces Bacterial Cell Death by DNA Damage and Inhibition of Cell Division. Free Radical Biology and Medicine, 120, 62-71.
https://doi.org/10.1016/j.freeradbiomed.2018.03.021
|
[49]
|
Nanni, V., Di Marco, G., Sacchetti, G., Canini, A. and Gismondi, A. (2020) Oregano Phytocomplex Induces Programmed Cell Death in Melanoma Lines via Mitochondria and DNA Damage. Foods, 9, Article No. 1486.
https://doi.org/10.3390/foods9101486
|
[50]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E. and Jemal, A. (2021) Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 71, 7-33. https://doi.org/10.3322/caac.21654
|
[51]
|
Rustgi, A.K. and El-Serag, H.B. (2014) Esophageal Carcinoma. New England Journal of Medicine, 371, 2499-2509.
https://doi.org/10.1056/NEJMra1314530
|
[52]
|
Jiang, R., Huan, Y., Li, Y., et al. (2022) Transcriptional and Genetic Alterations of Cuproptosis-Related Genes Correlated to Malignancy and Immune-Infiltrate of Esophageal Carcinoma. Cell Death Discovery, 8, Article No. 370.
https://doi.org/10.1038/s41420-022-01164-5
|
[53]
|
Lavilla, I., Costas, M., Miguel, P.S., Millos, J. and Bendicho, C. (2009) Elemental Fingerprinting of Tumorous and Adjacent Non-Tumorous Tissues From Patients with Colorectal Can-cer Using ICP-MS, ICP-OES and Chemometric Analysis. BioMetals, 22, 863-875. https://doi.org/10.1007/s10534-009-9231-6
|
[54]
|
Majumder, S., Chatterjee, S., Pal, S., et al. (2009) The Role of Copper in Drug-Resistant Murine and Human Tumors. BioMetals, 22, 377-384. https://doi.org/10.1007/s10534-008-9174-3
|
[55]
|
Xu, W.K., Byun, H. and Dudley, J.P. (2020) The Role of APO-BECs in Viral Replication. Microorganisms, 8, Article No. 1899. https://doi.org/10.3390/microorganisms8121899
|
[56]
|
Elango, R., Osia, B., Harcy, V., et al. (2019) Repair of Base Damage within Break-Induced Replication Intermediates Promotes Kataegis Associated with Chromosome Rearrange-ments. Nucleic Acids Research, 47, 9666-9684.
https://doi.org/10.1093/nar/gkz651
|
[57]
|
Shi, M.-J., Meng, X.-Y., Fontugne, J., et al. (2020) Identification of New Driver and Passenger Mutations within APOBEC-Induced Hotspot Mutations in Bladder Cancer. Genome Medicine, 12, Article No. 85.
https://doi.org/10.1186/s13073-020-00781-y
|
[58]
|
Zhou, B., Guo, L., Zhang, B., et al. (2019) Disulfiram Combined with Copper Induces Immunosuppression via PD-L1 Stabilization in Hepatocellular Carcinoma. American Journal of Cancer Research, 9, 2442-2455.
|
[59]
|
Simoni, Y., Becht, E., Fehlings, M., et al. (2018) Bystander CD8+ T Cells Are Abundant and Phenotypically Distinct in Human Tumor Infiltrates. Nature, 557, 575-579. https://doi.org/10.1038/s41586-018-0130-2
|
[60]
|
Meier, S.L., Satpathy, A.T. and Wells, D.K. (2022) Bystander T Cells in Cancer Immunology and Therapy. Nature Cancer, 3, 143-155. https://doi.org/10.1038/s43018-022-00335-8
|
[61]
|
Yamaguchi, H., Hsu, J.-M., Yang, W.-H. and Hung, M.-C. (2022) Mechanisms Regulating PD-L1 Expression in Cancers and Associated Opportunities for Novel Small-Molecule Therapeutics. Nature Reviews Clinical Oncology, 19, 287-305. https://doi.org/10.1038/s41571-022-00601-9
|
[62]
|
Haraldsdottir, S., Einarsdottir, H.M., Smaradottir, A., et al. (2022) Colorectal Cancer—A Review. Laeknabladid, 100, 75-82.
|
[63]
|
Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108. https://doi.org/10.3322/caac.21262
|
[64]
|
Baidoun, F., Elshiwy, K., Elkeraie, Y., et al. (2021) Colorectal Cancer Ep-idemiology: Recent Trends and Impact on Outcomes. Current Drug Targets, 22, 998-1009. https://doi.org/10.2174/18735592MTEx9NTk2y
|
[65]
|
Sheftel, A.D., Stehling, O., Pierik, A.J., et al. (2010) Hu-mans Possess Two Mitochondrial Ferredoxins, Fdx1 and Fdx2, with Distinct Roles in Steroidogenesis, Heme, and Fe/S Cluster Biosynthesis. Proceedings of the National Academy of Sciences of the United States of America, 107, 11775-11780. https://doi.org/10.1073/pnas.1004250107
|
[66]
|
Strushkevich, N., MacKenzie, F., Cherkesova, T., et al. (2011) Structural Basis for Pregnenolone Biosynthesis by the Mitochondrial Monooxygenase System. Proceedings of the National Academy of Sciences of the United States of America, 108, 10139-10143. https://doi.org/10.1073/pnas.1019441108
|
[67]
|
Wang, Z., Dong, H., Yang, L., et al. (2021) The Role of FDX1 in Granulosa Cell of Polycystic Ovary Syndrome (PCOS). BMC Endocrine Disorders, 21, Article No. 119. https://doi.org/10.1186/s12902-021-00775-w
|
[68]
|
Wang, L., Cao, Y., Guo, W. and Xu, J. (2023) High Expression of Cuproptosis-Related Gene FDX1 in Relation to Good Prognosis and Immune Cells Infiltration in Colon Adenocarci-noma (COAD). Journal of Cancer Research and Clinical Oncology, 149, 15-24. https://doi.org/10.1007/s00432-022-04382-7
|
[69]
|
O’Shaughnessy, M.J., Murray, K.S., La Rosa, S.P., et al. (2018) Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors. Clinical Cancer Research, 24, 592-599. https://doi.org/10.1158/1078-0432.CCR-17-0186
|
[70]
|
Buas, M.F., He, Q., Johnson, L.G., et al. (2017) Germline Variation in Inflammation-Related Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma. Gut, 66, 1739-1747.
https://doi.org/10.1136/gutjnl-2016-311622
|
[71]
|
Ha, J.H., Jayaraman, M., Yan, M., et al. (2021) GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules, 11, Article No. 1211. https://doi.org/10.3390/biom11081211
|
[72]
|
Ma, X., Zhang, Q., Du, J., Tang, J. and Tan, B. (2021) Integrat-ed Analysis of ceRNA Regulatory Network Associated with Tumor Stage in Cervical Cancer. Frontiers in Genetics, 12, Article 618753.
https://doi.org/10.3389/fgene.2021.618753
|
[73]
|
Rimal, R., Desai, P., Marquez, A.B., et al. (2021) 3-D Vascular-ized Breast Cancer Model to Study the Role of Osteoblast in Formation of a Pre-Metastatic Niche. Scientific Reports, 11, Article No. 21966.
https://doi.org/10.1038/s41598-021-01513-x
|
[74]
|
Ding, H., Zhang, X., Su, Y., Jia, C. and Dai, C. (2020) GNAS Promotes Inflammation-Related Hepatocellular Carcinoma Progression by Promoting STAT3 Activation. Cellular & Molecular Biology Letters, 25, Article No. 8.
https://doi.org/10.1186/s11658-020-00204-1
|
[75]
|
Duperret, E.K., Trautz, A., Ammons, D., et al. (2018) Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice. Clinical Cancer Research, 24, 1190-1201. https://doi.org/10.1158/1078-0432.CCR-17-2033
|
[76]
|
Elyada, E., Bolisetty, M., Laise, P., et al. (2019) Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Can-cer-Associated Fibroblasts. Cancer Discovery, 9, 1102-1123.
https://doi.org/10.1158/2159-8290.CD-19-0094
|
[77]
|
Olusola, P., Banerjee, H.N., Philley, J.V. and Dasgupta, S. (2019) Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells, 8, Article No. 622. https://doi.org/10.3390/cells8060622
|
[78]
|
Lei, J., Ploner, A., Elfström, K.M., et al. (2020) HPV Vaccination and the Risk of Invasive Cervical Cancer. New England Journal of Medicine, 383, 1340-1348. https://doi.org/10.1056/NEJMoa1917338
|
[79]
|
Lei, L., Tan, L. and Sui, L. (2022) A Novel Cuproptosis-Related Gene Signature for Predicting Prognosis in Cervical Cancer. Frontiers in Genetics, 13, Article 957744. https://doi.org/10.3389/fgene.2022.957744
|
[80]
|
Wang, L., Kaneko, S., Kagaya, M., et al. (2002) Molecular Clon-ing, and Characterization and Expression of Dihydrolipoamide Acetyltransferase Component of Murine Pyruvate Dehy-drogenase Complex in Bile Duct Cancer Cells. Journal of Gastroenterology, 37, 449-454. https://doi.org/10.1007/s005350200065
|
[81]
|
Li, Y., Huang, R., Li, X., et al. (2016) Decreased Expression of Py-ruvate Dehydrogenase A1 Predicts an Unfavorable Prognosis in Ovarian Carcinoma. American Journal of Cancer Re-search, 6, 2076-2087.
|
[82]
|
Song, L., Liu, D., Zhang, X., et al. (2019) Low Expression of PDHA1 Predicts Poor Prog-nosis in Gastric Cancer. Pathology-Research and Practice, 215, 478-482. https://doi.org/10.1016/j.prp.2018.12.038
|
[83]
|
Chen, J., Guccini, I., Di Mitri, D., et al. (2018) Compartmentalized Activities of the Pyruvate Dehydrogenase Complex Sustain Lipogenesis in Prostate Cancer. Nature Genetics, 50, 219-228. https://doi.org/10.1038/s41588-017-0026-3
|
[84]
|
Li, D., Wang, C., Ma, P., et al. (2018) PGC1α Promotes Cholangiocarcinoma Metastasis by Upregulating PDHA1 and MPC1 Expression to Reverse the Warburg Effect. Cell Death & Disease, 9, Article No. 466.
https://doi.org/10.1038/s41419-018-0494-0
|
[85]
|
Ishida, S., McCormick, F., Smith-McCune, K. and Hanahan, D. (2010) Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator. Cancer Cell, 17, 574-583. https://doi.org/10.1016/j.ccr.2010.04.011
|
[86]
|
Gao, W., Huang, Z., Duan, J., et al. (2021) Elesclomol In-duces Copper-Dependent Ferroptosis in Colorectal Cancer Cells via Degradation of ATP7A. Molecular Oncology, 15, 3527-3544. https://doi.org/10.1002/1878-0261.13079
|
[87]
|
Henning, A.N., Roychoudhuri, R. and Restifo, N.P. (2018) Epigenetic Control of CD8+ T Cell Differentiation. Nature Reviews Immunology, 18, 340-356. https://doi.org/10.1038/nri.2017.146
|
[88]
|
Hodgins, J.J., Khan, S.T., Park, M.M., Auer, R.C. and Ardolino, M. (2019) Killers 2.0: NK Cell Therapies at the Forefront of Cancer Control. Journal of Clinical Investigation, 129, 3499-3510. https://doi.org/10.1172/JCI129338
|
[89]
|
Liang, Y., Hannan, R. and Fu, Y.-X. (2021) Type I IFN Acti-vating Type I Dendritic Cells for Antitumor Immunity. Clinical Cancer Research, 27, 3818-3824. https://doi.org/10.1158/1078-0432.CCR-20-2564
|
[90]
|
Kahlson, M.A. and Dixon, S.J. (2022) Copper-Induced Cell Death. Science, 375, 1231-1232.
https://doi.org/10.1126/science.abo3959
|